ORLANDO ‑- Cataract surgery was linked to an increased risk of conversion from dry to neovascular (wet) age-related macular degeneration (AMD) in a large retrospective cohort study, although the ...
The evidence evaluating the effect of cataract surgery on the chances people with dry age-related macular degeneration (AMD) will convert to the more severe wet form of the condition has been uneven ...
There's been extensive debate over the risk of neovascular age-related macular degeneration (AMD) after cataract surgery. In a large retrospective cohort study, the risk of neovascular AMD was similar ...
The MarketWatch News Department was not involved in the creation of this content. Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class ...
Please provide your email address to receive an email when new articles are posted on . Central retinal thickness and macular volume increased at 2 months postop but returned to preop levels at 6 ...
Age-related macular degeneration (AMD) remains a leading cause of vision loss globally, with significant advancements in treatment options for both dry and wet AMD. As highlighted by Huang and ...
Needham initiated coverage on Ocular Therapeutix Inc (NASDAQ:OCUL), noting the company’s lead asset, Axpaxli, an investigational axitinib-based intravitreal implant for wet age-related macular ...
WATERTOWN, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...
Clearside Biomedical, Inc. announced on March 20, 2025, that it presented findings on its lead clinical program, CLS-AX, a suprachoroidal injectable suspension of axitinib, at the 2025 Wet AMD & ...
Cataract surgery was not associated with neovascular ("wet") age-related macular degeneration (nAMD), even among patients with pre-existing cases of non-neovascular ("dry") AMD, according to a large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results